BAPRS BIA ALCL STATEMENT JULY 2021

For the avoidance of any doubt, we wish to confirm our advice to the members of our association in respect of consenting patients regarding breast implants.

In March 2015 BAPRAS released a press statement that can be read here.

This was a solitary notification at that time relative to the accumulating but limited scientific evidence about ALCL at that stage. The diagnosis of Breast Implant Associated ALCL was announced in the literature in May 2016 by the World Health Organisation as a new tumour (BLOOD, 19 MAY 2016. VOLUME 127, NUMBER 20), this was not in a mainstream plastic surgery journal. Consequently the first major guidance that BAPRAS endorsed along with ABS and BAAPS was the the guidance issued by the MHRA with effect from 25th July 2018.

Find out more.